Found 7 matching trials
Combined Use of Apatinib Mesylate and Vinorelbine Versus Single Use of Vinorelbine in Triple-negative Breast Cancer PHASE2 To compare the therapeutic effect of vinorelbine used alone or combined wit...
Show More Location
Multiple Locations
Learn More & Join Trial
Apatinib Combined With Vinorelbine for Non-driver Gene Mutation Non-small Cell Lung Cancer PHASE2 The purpose of this study is to assess the safety and effectiveness of Apat...
Show More Location
Hunan Provincal Tumor Hospital
Learn More & Join Trial
Fluorizoparib Plus Apatinib Versus Chemotherapy in HRD-positive, HER2-negative Advanced Breast Cancer PHASE3 This is a Phase III clinical trial for patients with a specific type of adv...
Show More Status
Active Not Recruiting
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Learn More & Join Trial
A Multicenter Clinical Study of Apatinib Mesylate Combined With Doctor's Choice for Advanced Breast Cancer PHASE2 Previous studies have found good efficacy of (investigator's choice of chem...
Show More Location
Multiple Locations
Learn More & Join Trial
Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer PHASE2 The hypothesis of this study is to discover if the all-oral therapy with ap...
Show More Location
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Learn More & Join Trial
Randomized, Open, Controlled, Multicenter Phase III Clinical Study of Fluzoparib in Combination With Apatinib Versus Investigator-Selected Chemotherapy for HRD-Positive/HER2-negative Advanced Breast Cancer PHASE3 This study develops a new therapeutic approach for HER2-negative advanced b...
Show More Location
Sun Yat Sen Memorial Hospital,Sun Yat sen University
Learn More & Join Trial
Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing PHASE2 Patients with salivary gland carcinoma were divided into groups according t...
Show More Learn More & Join Trial